Efficacy of rocatinlimab for moderate-to-severe atopic dermatitis

被引：3
|
作者：
Devjani, Shivali [1 ]
Engel, Priya, V [2 ]
Javadi, Sogol S. [3 ]
Smith, Brandon [4 ]
Wu, Jashin J. [5 ]
机构：
[1] SUNY Downstate, Coll Med, New York, NY USA
[2] Calif Univ Sci & Med, Colton, CA USA
[3] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA USA
[4] Drexel Univ, Coll Med, Philadelphia, PA USA
[5] Univ Miami, Miller Sch Med, Dept Dermatol, Miami, FL 33136 USA
来源：
LANCET | 2023年 / 402卷 / 10415期
关键词：
D O I：
10.1016/S0140-6736(23)01619-7
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1833 / 1834
页数：2
相关论文
共 50 条
  • [1] Efficacy of rocatinlimab for moderate-to-severe atopic dermatitis - Authors' reply
    Guttman-Yassky, Emma
    Simpson, Eric L.
    Reich, Kristian
    Kabashima, Kenji
    Igawa, Ken
    Suzuki, Tetsuya
    Mano, Hirotaka
    Matsui, Takeshi
    Esfandiari, Ehsanollah
    Furue, Masutaka
    LANCET, 2023, 402 (10415): : 1834 - 1834
  • [2] ROCKET: a phase 3 program evaluating the efficacy and safety of rocatinlimab in moderate-to-severe atopic dermatitis
    Guttman-Yassky, Emma
    Simpson, Eric
    Bissonnette, Robert
    Eichenfield, Lawrence F.
    Kabashima, Kenji
    Luna, Paula C.
    Hercogova, Jana Tresnak
    Spelman, Lynda
    Worm, Margitta
    Esfandiari, Ehsanollah
    Arai, Takahiro
    Mano, Hirotaka
    Charuworn, Prista
    Wang, Andrea
    Kricorian, Gregory
    IMMUNOTHERAPY, 2025, 17 (02) : 83 - 94
  • [3] Lebrikizumab for Moderate-to-Severe Atopic Dermatitis
    Smith, Brandon I.
    Engel, Priya
    Wu, Jashin
    NEW ENGLAND JOURNAL OF MEDICINE, 2023, 388 (24): : 2299 - 2300
  • [4] Efficacy of dupilumab in atopic comorbidities associated with moderate-to-severe adult atopic dermatitis
    Nettis, Eustachio
    Patella, Vincenzo
    Lombardo, Carla
    Detoraki, Aikaterini
    Macchia, Luigi
    Di Leo, Elisabetta
    Carbonara, Monica
    Canonica, Giorgio W.
    Bonzano, Laura
    ALLERGY, 2020, 75 (10) : 2653 - 2661
  • [5] Efficacy and safety of dupilumab for the treatment of moderate-to-severe atopic dermatitis in adults
    Zheng, Y.
    BRITISH JOURNAL OF DERMATOLOGY, 2019, 181 : 72 - 72
  • [6] Efficacy and safety of ustekinumab treatment in adults with moderate-to-severe atopic dermatitis
    Khattri, Saakshi
    Brunner, Patrick M.
    Garcet, Sandra
    Finney, Robert
    Cohen, Steven R.
    Oliva, Margeaux
    Dutt, Riana
    Fuentes-Duculan, Judilyn
    Zheng, Xiuzhong
    Li, Xuan
    Bonifacio, Kathleen M.
    Kunjravia, Norma
    Coats, Israel
    Cueto, Inna
    Gilleaudeau, Patricia
    Sullivan-Whalen, Mary
    Suarez-Farinas, Mayte
    Krueger, James G.
    Guttman-Yassky, Emma
    EXPERIMENTAL DERMATOLOGY, 2017, 26 (01) : 28 - 35
  • [7] Evaluating the safety and efficacy of baricitinib for the treatment of moderate-to-severe atopic dermatitis
    Bridgeman, Sarah G.
    Martino, Anna K.
    Strowd, Lindsay C.
    EXPERT OPINION ON PHARMACOTHERAPY, 2023, 24 (18) : 2153 - 2159
  • [8] Safety and Efficacy of Tralokinumab in Older Adults With Moderate-to-Severe Atopic Dermatitis
    Merola, Joseph F.
    Butler, Daniel C.
    Mark, Thomas
    Schneider, Shannon
    Kim, Yestle
    Abuabara, Katrina
    JAMA DERMATOLOGY, 2023, 159 (10) : 1119 - 1123
  • [9] Efficacy and safety of dupilumab for the treatment of moderate-to-severe atopic dermatitis in adults
    Xu, Xinghua
    Zheng, Yi
    Zhang, Xin
    He, Yanling
    Li, Chengxin
    ONCOTARGET, 2017, 8 (65) : 108480 - 108491
  • [10] Efficacy of abrocitinib monotherapy for the treatment of moderate-to-severe atopic dermatitis by race
    Alexis, A. F.
    Silverberg, J. I.
    Rice, Z. P.
    Armstrong, A. W.
    Desai, S. R.
    Fonacier, L.
    Kabashima, K.
    Levenberg, M.
    Biswas, P.
    Cella, R. Rojo
    Chan, G. L.
    BRITISH JOURNAL OF DERMATOLOGY, 2021, 185 (03) : E137 - E138
12345